233 related articles for article (PubMed ID: 35554919)
1. Strengthening Biorisk Management in Research Laboratories with Security-Sensitive Biological Agents Like SARS-CoV-2.
Phyu S; Joseph T; Goulart M
Methods Mol Biol; 2022; 2452():395-439. PubMed ID: 35554919
[TBL] [Abstract][Full Text] [Related]
2. Biorisk Management for SARS-CoV-2 Research in a Biosafety Level-3 Core Facility.
Joseph T; Phyu S; Se-Thoe SY; Chu JJH
Methods Mol Biol; 2022; 2452():441-464. PubMed ID: 35554920
[TBL] [Abstract][Full Text] [Related]
3. Assessment of biorisk management systems in high containment laboratories, 18 countries in Europe, 2016 and 2017.
Appelt S; Jacob D; Rohleder AM; Bråve A; Szekely Björndal Å; Di Caro A; Grunow R;
Euro Surveill; 2020 Sep; 25(36):. PubMed ID: 32914748
[TBL] [Abstract][Full Text] [Related]
4. Strengthening Biorisk Management Capacities in Burkina Faso: Contribution of the Global Health Security Agenda.
Dama E; Orelle A; Nikiema A; Mandingar PD; Naby A; Bationo GB; Kéita MS; Pierson A; Sawadogo C; Koné RG
Health Secur; 2022; 20(6):479-487. PubMed ID: 36399610
[TBL] [Abstract][Full Text] [Related]
5. [Biorisk Management for Clinical Diagnostic Laboratories].
Shigematsu M
Rinsho Byori; 2016 Nov; 64(11):1279-1289. PubMed ID: 30695310
[TBL] [Abstract][Full Text] [Related]
6. Management System Approach for Addressing Biosafety and Biosecurity of Emerging Pathogens in a Biosafety Level-3 Core Facility.
Joseph T
Appl Biosaf; 2021 Dec; 26(4):210-220. PubMed ID: 36034099
[No Abstract] [Full Text] [Related]
7. A Cross-Sectional Survey to Assess Biorisk Management System in Research and Diagnostic Laboratories in Khyber Pakhtunkhwa, Pakistan.
Muhammad J; Sarwar S; Khan T; Qasmi SA; Ikram A; Ahmad G; Zahid M; Durrani RH; Ahmed F
Front Public Health; 2021; 9():766162. PubMed ID: 34976925
[TBL] [Abstract][Full Text] [Related]
8. Motivating Proactive Biorisk Management.
Greene D; Palmer MJ; Relman DA
Health Secur; 2023; 21(1):46-60. PubMed ID: 36633603
[TBL] [Abstract][Full Text] [Related]
9. WHO Laboratory Biosafety Manual: A New Approach to Security.
Ficociello B; Giordano D; Incoronato F; Farinella A; Pietrangeli B
Ann Work Expo Health; 2023 Apr; 67(4):425-429. PubMed ID: 36495279
[TBL] [Abstract][Full Text] [Related]
10. The Biosafety Research Road Map: The Search for Evidence to Support Practices in Human and Veterinary Laboratories.
Blacksell SD; Dhawan S; Kusumoto M; Le KK; Summermatter K; O'Keefe J; Kozlovac J; Almuhairi SS; Sendow I; Scheel CM; Ahumibe A; Masuku ZM; Bennett AM; Kojima K; Harper DR; Hamilton K
Appl Biosaf; 2023 Jun; 28(2):64-71. PubMed ID: 37342514
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of international virtual training on biorisk management in the context of COVID-19.
Qasmi SA; Standley C; Mohsin S; Sarwar S; Malik L; Aziz F
Front Public Health; 2022; 10():888097. PubMed ID: 36339241
[TBL] [Abstract][Full Text] [Related]
12. A Multilingual Tool for Standardized Laboratory Biosafety and Biosecurity Assessment and Monitoring.
Orelle A; Nikiema A; Zakaryan A; Albetkova AA; Keita MS; Rayfield MA; Peruski LF; Pierson A
Health Secur; 2022; 20(6):488-496. PubMed ID: 36383124
[TBL] [Abstract][Full Text] [Related]
13. The Biosafety Research Road Map: The Search for Evidence to Support Practices in the Laboratory-SARS-CoV-2.
Blacksell SD; Dhawan S; Kusumoto M; Le KK; Summermatter K; O'Keefe J; Kozlovac J; Almuhairi SS; Sendow I; Scheel CM; Ahumibe A; Masuku ZM; Kojima K; Harper DR; Hamilton K
Appl Biosaf; 2023 Jun; 28(2):87-95. PubMed ID: 37342515
[TBL] [Abstract][Full Text] [Related]
14. Biosafety and biosecurity measures: management of biosafety level 3 facilities.
Zaki AN
Int J Antimicrob Agents; 2010 Nov; 36 Suppl 1():S70-4. PubMed ID: 20801002
[TBL] [Abstract][Full Text] [Related]
15. Understanding Biosafety and Biosecurity in Ukraine.
Houser RS; Koblentz GD; Lentzos F
Health Secur; 2023; 21(1):70-80. PubMed ID: 36629857
[TBL] [Abstract][Full Text] [Related]
16. Harmonization of European laboratory response networks by implementing CWA 15793: use of a gap analysis and an "insider" exercise as tools.
Sundqvist B; Bengtsson UA; Wisselink HJ; Peeters BP; van Rotterdam B; Kampert E; Bereczky S; Johan Olsson NG; Szekely Björndal A; Zini S; Allix S; Knutsson R
Biosecur Bioterror; 2013 Sep; 11 Suppl 1():S36-44. PubMed ID: 23971820
[TBL] [Abstract][Full Text] [Related]
17. National Biosafety Management System: A Combined Framework Approach Based on 15 Key Elements.
Orelle A; Nikiema A; Zakaryan A; Albetkova AA; Rayfield MA; Peruski LF; Pierson A; Kachuwaire O
Front Public Health; 2021; 9():609107. PubMed ID: 34368035
[TBL] [Abstract][Full Text] [Related]
18. Implementation of Active Learning Approach to Teach Biorisk Management and Dual-Use Research of Concern in Egypt.
Elhadidy M; El-Tholoth M; Brocard AS
Appl Biosaf; 2019 Jun; 24(2):100-110. PubMed ID: 36033939
[TBL] [Abstract][Full Text] [Related]
19. Biosafety measures for preventing infection from COVID-19 in clinical laboratories: IFCC Taskforce Recommendations.
Lippi G; Adeli K; Ferrari M; Horvath AR; Koch D; Sethi S; Wang CB
Clin Chem Lab Med; 2020 Jun; 58(7):1053-1062. PubMed ID: 32396137
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the Biorisk Status of Veterinary Laboratories in Southwest Nigeria: Application of the Food and Agriculture Organization Laboratory Mapping Tool-Safety Module.
Adebowale O; Oduguwa A; Dipeolu S; Agbaje M; Fasanmi O; Fasina FO
Appl Biosaf; 2020 Dec; 25(4):232-239. PubMed ID: 36032392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
